Clinical Trials Logo

Lung Cancer clinical trials

View clinical trials related to Lung Cancer.

Filter by:

NCT ID: NCT05173337 Completed - Lung Cancer Clinical Trials

Nefopam as a Multimodal Analgesia for Thoracic Surgery

Start date: December 8, 2021
Phase: N/A
Study type: Interventional

Acute postoperative pain after video-assisted thoracoscopic surgery is very severe. Because pain after thoracic surgery prevents early recovery, and increases postoperative complications, its is important to prevent pain after video-assisted thoracoscopic surgery. In the present study, we will evaluate whether nefopam reduces pain after video-assisted thoracoscopic surgery.

NCT ID: NCT05164445 Completed - Lung Cancer Clinical Trials

The Role of Interventional Pulmonology, Microbiota and Immune Response in the Patient With Lung Cancer

RIPMIRLC
Start date: September 1, 2019
Phase: N/A
Study type: Interventional

This study is designed to evaluate complications, specificity, diagnostic yield of radial endobronchial ultrasound guided transbronchial cryobiopsy and transbronchial forceps biopsy with fluoroscopy in the diagnosis of peripheral pulmonary lesion; the interplay between non-small-cell lung cancer associated-bacteria along the gut-lung axis and immune response in the cancer microenvironment.

NCT ID: NCT05160571 Completed - Lung Cancer Clinical Trials

A Retrospective Multicenter Review to Evaluate the Performance of the Ion Endoluminal System in Sampling Pulmonary Lesions

Start date: November 1, 2021
Phase:
Study type: Observational

This study is a retrospective multi-center chart review of patients who underwent an attempted biopsy of one or more pulmonary lesion(s) with the Ion Endoluminal System with the aim of assessing the overall performance of the system.

NCT ID: NCT05151419 Completed - Lung Cancer Clinical Trials

Forceps Biopsy Versus Cryo-biopsy in the Diagnosis of Lung Cancer

Start date: July 21, 2020
Phase: N/A
Study type: Interventional

This study was comprised of 30 patients who were scheduled for a diagnostic bronchoscopy due to a suspicion of lung cancer in order to obtain tissue samples for a final diagnosis , four biopsies were taken by each of cryobiopsy and forceps biopsy , to evaluate and compare the diagnostic yield of endobronchial cryobiopsy and forceps biopsy in the diagnosis of lung cancer .

NCT ID: NCT05137782 Completed - Lung Cancer Clinical Trials

The Science of the Art of Palliative Care

Start date: January 3, 2023
Phase: N/A
Study type: Interventional

This feasibility pilot study is designed to learn whether patients and their care partners (e.g., family members) are willing and able to complete two study visits at Dartmouth College while receiving cancer care at Dartmouth-Hitchcock Medical Center.

NCT ID: NCT05137067 Completed - Breast Cancer Clinical Trials

A Novel Approach for Alleviating the Side Effects of Chemotherapeutic Agents.

Start date: January 20, 2021
Phase: Phase 2
Study type: Interventional

This study will assess the effectiveness of a natural nutraceutical in treating the known side effects of chemotherapeutic agents in cancer patients.

NCT ID: NCT05121259 Completed - Lung Cancer Clinical Trials

Feasibility and Acceptability of an Web-based Physical Activity Program, for Those Diagnosed With Lung Cancer.

Start date: November 22, 2021
Phase: N/A
Study type: Interventional

Lung cancer is a life changing disease which can cause negative effects on an individual's ability to perform daily tasks and their quality of life (QoL). Lung cancer is the third most common cancer in the UK and is estimated affects approximately 33,000 individuals per year. The most common side effects from lung cancer and treatments are breathlessness, fatigue, nausea, diarrhoea, and depression. Those living beyond cancer often suffer from extreme feelings of isolation and have increased chance of cardiovascular disease and diabetes. Physical activity is a vital component of the prevention and management of cancer. Being active can improve one's physical health (ability to carry out tasks of daily living and breathlessness) and emotional wellbeing (feelings of depression and isolation). Electronic platforms (websites and mobile applications) are increasingly popular within developing nations, particularly with products that aim to increase and keep track of physical activity. Though, literature suggests older adults prefer websites opposed to mobile applications. Online delivery of physical activity could be highly beneficial for patients living with and beyond cancer, reducing the location-based inequality of those who can not attend face-to-face programmes, allowing individuals to carry out a session whenever they can, in the comfort of their own home. Exploring how those living with and beyond lung cancer use a website and investigating the feasibility and acceptability on an online platform which aims to provide tailored physical activity programs will provide fundamental data and possible supporting data for a randomised controlled trail (RCT).

NCT ID: NCT05082636 Completed - Lung Cancer Clinical Trials

The Role of Programmed Death Ligand -1 (Pdl-1) in Lung Cancer

Start date: June 15, 2018
Phase:
Study type: Observational [Patient Registry]

This study was designed to investigate the correlation of lung cancer tissue expression of both PDL-1-mRNA ,vitamin D receptor (VDR) and level of vit.D in sera of lung cancer patients.These three biochemical markers may interact and play a role in lung cancer progression.

NCT ID: NCT05071014 Completed - Lung Cancer Clinical Trials

A Study of Pembrolizumab and Cryoablation in People With Mesothelioma

Start date: September 24, 2021
Phase: Phase 1
Study type: Interventional

The researchers are doing this study to find out whether the combination of pembrolizumab and cryoablation is a safe treatment that causes few or mild side effects in people with mesothelioma. The researchers will also look at whether the combination of pembrolizumab and cryoablation is effective against participants' cancer.

NCT ID: NCT05067738 Completed - Lung Cancer Clinical Trials

Same Day Discharge for Wedge Resection

Start date: February 1, 2022
Phase: N/A
Study type: Interventional

Monitoring carefully selected participants to determine if participants can be safely discharged the same day of pulmonary resection